menu search

Senti Bio to Present at the SVB Securities Global Biopharma Conference

Senti Bio to Present at the SVB Securities Global Biopharma Conference
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit technology platform, today announced that Tim Lu, MD, PhD, Senti’s Co-Founder and CEO, will present at the SVB Securities Global Biopharma Conference. Event details: […] The post Senti Bio to Present at the SVB Securities Global Biopharma Conference appeared first on ForexT... Read More
Posted: Feb 1 2023, 21:05
Author Name: forextv
Views: 111773

Search within

Pages Search Results: